Check out the latest studies, management strategies, patient advocacy, and other important news involving this condition.
LPOXY Therapeutics Acquires Assets to Advance C difficile Protection for Antibiotic Patients
C difficile, Antimicrobials, and the Patients Most Affected
Could the Flight or Fight Response Trigger Severe C difficile?
Top 5 Infectious Disease News Stories Week of December 14-20
While Hospital-Acquired C difficile Cases Have Decreased, Community-Acquired Cases Have Risen
Investigational Therapeutic for Recurrent C Difficile Reduces Antibiotic Resistant Genes